Latest News
SCAM ALERT- no Lawley job offers in USA
Over the past few days a number of people in the USA have contacted Lawley Pharmaceuticals verifying the bona fides of a work from… Continue Reading →
COVID-19 – Changes to Lawley Pharmaceuticals operations
COVID-19 – Changes to Lawley Pharmaceuticals operations During large scale health crises, the continued supply of medicines is an essential service to the community…. Continue Reading →
TGA accepts Lawley product for evaluation in postmenopausal women with HSDD.
TGA accepts Lawley product for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019 — Lawley Pharmaceuticals Pty Ltd today announced… Continue Reading →
Gender disparity in sexual health options for women: Experts call on pharma and drug regulators to address
In 2015 Comment in the prestigious medical journal Lancet Diabetes & Endocrinology by two of the world’s leading female sexual health specialists, Prof…. Continue Reading →
Menopause specialists warn against dangers of “bioidentical hormones”
On Monday 15th July 2019 in a comprehensive interview on the Life Matters program (ABC Radio National) two of Australia’s premier menopause specialists, Dr Elizabeth Farrell and… Continue Reading →
BBC Menopause and testosterone replacement therapy
Over 900 specialist menopause physicians from around the world attended The European Menopause and Andropause Society conference held in Berlin on 15-17th May 2019. Numerous… Continue Reading →
Hypoactive Sexual Desire Disorder (HSDD) re-defined
In late 2018 the World Health Organisation (WHO) released an update to The International Classification of Disease (ICD). ICD is a system of medical coding created… Continue Reading →
Federal Court Proceedings Demonstrate Risk To Compounding Pharmacies
MEDIA RELEASE 3rd August 2017 A recent Federal Court case highlights the very real risk and cost to Compounding Pharmacies who do not… Continue Reading →
FDA releases Industry Guidance for Low Sexual Interest, Desire and/or Arousal in Women
In late October 2016 the US FDA released draft guidance for Industry on Low Sexual Interest, Desire, and/or Arousal in Women: Developing Drugs for Treatment. … Continue Reading →
Flibanserin, the drug that gives women one extra sexually satisfying experience every two months
Flibanserin, the drug that gives women one extra sexually satisfying experience every two months